Tissue-engineered three-dimensional in vitro models for normal and diseased kidney

Tissue Engineering - Part A

Volumn 16, Issue 9, 2010, Pages 2821-2831

  Subramanian, Balajikarthick ^a,b   Rudym, Darya ^a,c   Cannizzaro, Chris ^a   Perrone, Ronald ^c   Zhou, Jing ^d   Kaplan, David L ^a  

^a Tufts University   (United States)

^b UNIVERSITY OF MASSACHUSETTS LOWELL   (United States)

^c TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOREACTORS; CELL CULTURE; MORPHOLOGY; SELF ASSEMBLY; SODIUM; TISSUE;

AUTOSOMAL-DOMINANT POLYCYSTIC KIDNEY DISEASE; CARBOXY FLUORESCEINS; CELL TYPES; CELLULAR UPTAKE; CO-CULTURE SYSTEM; DRUG SCREENING; E-CADHERINS; EPITHELIAL CELLS; EPITHELIAL TISSUE; EXTRACELLULAR MATRIX MOLECULES; FUNCTIONAL FEATURES; IN-VITRO; INTERCELLULAR INTERACTIONS; KIDNEY TISSUES; MATRIGEL; N-CADHERIN; ORGANIC ANIONS; PERFUSION BIOREACTOR; POTENTIAL UTILITY; SILK SCAFFOLD; THREE-DIMENSIONAL (3D); TIME-PERIODS; TISSUE STRUCTURE;

THREE DIMENSIONAL;

TISSUE SCAFFOLD;

ANIMAL; ARTICLE; ATOMIC FORCE MICROSCOPY; CELL LINE; CHEMISTRY; CYTOLOGY; EPITHELIUM CELL; FIBROBLAST; FLOW CYTOMETRY; KIDNEY; KIDNEY DISEASE; METABOLISM; METHODOLOGY; MOUSE; PATHOLOGY; SILKWORM; TISSUE ENGINEERING; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; BOMBYX; CELL LINE; EPITHELIAL CELLS; FIBROBLASTS; FLOW CYTOMETRY; KIDNEY; KIDNEY DISEASES; MICE; MICROSCOPY, ATOMIC FORCE; TISSUE ENGINEERING; TISSUE SCAFFOLDS;

EID: 77956065252     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2009.0595     Document Type: Article

References (50)

1. Bryant, D., and Mostov, K. From cells to organs: building polarized tissue. Nat Rev Mol Cell Biol 9, 887, 2008.
2. Patwari, P., and Lee, R.T. Mechanical control of tissue morphogenesis. Circ Res 103, 234, 2008.
3. Kim, J.B. Three dimensional tissue culture models in cancer biology. Semin Cancer Biol 15, 365, 2005.
4. Yamada, K., and Cukierman, E. Modeling tissue morphogenesis and cancer in 3D. Cell 130, 601, 2007.
5. Griffith, L.G., and Swartz, M.A. Capturing complex 3D tissue physiology in vitro. Nat Rev Mol Cell Biol 7, 211, 2006.
6. Torres, V.E., and Harris, P.C. Mechanism of disease: auto-somal dominant and recessive polycystic kidney disease. Nat Clin Pract Nephrol 2, 40, 2006.
7. Torres, V.E., Harris, P.C., and Prison, Y. Autosomal dominant polycystic kidney disease. Lancet 369, 1287, 2007.
8. Li, X., Luo, Y., Starremans, P.G., McNamara, C.A., Pei, Y., and Zhou, J. Polycystin-1 and polycystin-2 regulate the cell cycle through the helix-loop-helix inhibitor Id2. Nat Cell Biol 7, 1202, 2005.
9. Nauli, S.M., Alenghat, F.J., Luo, Y., Williams, E., Vassilev, P., Li, X., Elia, A.E., Lu, W., Brown, E.M., Quinn, S.J., Ingber, D.E., and Zhou, J. Polycystins 1 and 2 mediate mechan-osensation in the primary cilium of kidney cells. Nat Genet 33, 129, 2003.
10. Boca, M., D'Amato, L., Distefano, G., Polishchuk, R.S., Ger-mino, G.G., and Boletta, A. Polycystin-1 induces cell migration by regulating phosphatidylinositol 3-kinase-dependent cytoskeletal rearrangements and GSK3beta-dependent cell-cell mechanical adhesion. Mol Biol Cell 18, 4050, 2007.
11. Shillingford, J.M., Murcia, N.S., Larson, C.H., Low, S.H., Hedgepeth, R., Brown, N., Flask, C.A., Novick, A.C., Gold-farb, D.A., Kramer-Zucker, A., Walz, G., Piontek, K.B., Germino, G.G., and Weimbs, T. The mTOR pathway is regulated by polycystin-1, and its inhibition reverses renal cystogenesis in polycystic kidney disease. Proc Natl Acad Sci USA 103, 5466, 2006.
12. Lal, M., Song, X., Pluznick, J.L., Di Giovanni, V., Merrick, D.M., Rosenblum, N.D., Chauvet, V., Gottardi, C.J., Pei, Y., and Caplan, M.J. Polycystin-1 C-terminal tail associates with beta-catenin and inhibits canonical Wnt signaling. Hum Mol Genet 17, 3105, 2008.
13. Nauli, S.M., Rossetti, S., Kolb, R.J., Alenghat, F.J., Consugar, M.B., Harris, P.C., Ingber, D.E., Loghman-Adham, M., and Zhou, J. Loss of polycystin-1 in human cyst lining epithelia leads to ciliary dysfunction. J Am Soc Nephrol 17, 1015, 2006.
14. Shimazu, K., Toda, S., Miyazono, M., Sakemi, T., and Sugi-hara, H. Morphogenesis of MDCK cells in a collagen gel matrix culture under stromal adipocyte-epithelial cell interaction. Kidney Int 60, 568, 2001.
15. Okada, H., Ban, S., Nagao, S., Takahashi, H., Suzuki, H., and Neilson, E.G. Progressive renal fibrosis in murine polycystic kidney disease: an immunohistochemical observation. Kidney Int 58, 58, 2000.
16. Wilson, P.D. Mouse models of polycystic kidney disease. Curr Top Dev Biol 84, 311, 2008.
17. Pampaloni, F., Reynaud, E.G., and Stelzer, E.H. The third dimension bridges the gap between cell culture and live tissue. Nat Rev Mol Cell Biol 8, 839, 2007.
18. Altman, G.H., Diaz, F., Jakuba, C., Calabro, T., Horan, R.L., Chen, J., Lu, H., Richmond, J., and Kaplan, D.L. Silk-based biomaterials. Biomaterials 24, 401, 2003.
19. Kim, H.J., Kim, U.J., Kim, H.S., Li, C., Wada, M., Leisk, G.G., and Kaplan, D.L. Bone tissue engineering with pre-mineralized silk scaffolds. Bone 42, 1226, 2008.
20. Hanaoka, K., and Guggino, W.B. cAMP regulates cell proliferation and cyst formation in autosomal polycystic kidney disease cells. J Am Soc Nephrol 11, 1179, 2000.
21. Carone, F.A., Nakamura, S., Bacallao, R., Nelson, W.J., Khokha, M., and Kanwar, Y.S. Impaired tubulogenesis of cyst-derived cells from autosomal dominant polycystic kidneys. Kidney Int 47, 861, 1995.
22. Leroy, P., and Mostov, K.E. Slug is required for cell survival during partial epithelial-mesenchymal transition of HGF-induced tubulogenesis. Mol Biol Cell 18, 1943, 2007.
23. Daley, W.P., Peters, S.B., and Larsen, M. Extracellular matrix dynamics in development and regenerative medicine. J Cell Sci 121, 255, 2008.
24. Schrier, R.W. Renal volume, renin-angiotensin-aldosterone system, hypertension, and left ventricular hypertrophy in patients with autosomal dominant polycystic kidney disease. J Am Soc Nephrol 20, 1888, 2009.
25. Wright, S.H., and Dantzler, W.H. Molecular and cellular physiology of renal organic cation and anion transport. Physiol Rev 84, 987, 2004.
26. Minuth, W.W., Sittinger, M., and Kloth, S. Tissue engineering: generation of differentiated artificial tissues for bio-medical applications. Cell Tissue Res 29, 1, 1998
27. Fröhlich, M., Grayson, W.L., Marolt, D., Gimble, J.M., Kregar-Velikonja, N., and Vunjak-Novakovic, G. Bone grafts engineered from human adipose-derived stem cells in perfusion bioreactor culture. Tissue Eng Part A 16, 179, 2010.
28. Grayson, W.L., Bhumiratana, S., Cannizzaro, C., Chao, P.H., Lennon, D.P., Caplan, A.I., and Vunjak-Novakovic, G. Effects of initial seeding density and fluid perfusion rate on formation of tissue-engineered bone. Tissue Eng Part A 14, 1809, 2008.
29. Fischbach, C., Chen, R., Matsumoto, T., Schmelzle, T., Brugge, J.S., Polverini, P.J., and Mooney, D.J. Engineering tumors with 3D scaffolds. Nat Methods 4, 855, 2007.
30. Debnath, J., and Brugge, J.S. Modelling glandular epithelial cancers in three-dimensional cultures. Nat Rev Cancer 5, 675, 2005.
31. Wang, Y., Kim, U.J., Blasioli, D.J., Kim, H.J., and Kaplan, D.L. In vitro cartilage tissue engineering with 3D porous aqueous-derived silk scaffolds and mesenchymal stem cells. Biomaterials 26, 7082, 2005.
32. Elberg, G., Guruswamy, S., Logan, C.J., Chen, L., and Tur-man, M.A. Plasticity of epithelial cells derived from human normal and ADPKD kidneys in primary cultures. Cell Tissue Res 331, 495, 2008.
33. Evans, G.R., Brandt, K., Katz, S., Chauvin, P., Otto, L., Bogle, M., Wang, B., Meszlenyi, R.K., Lu, L., Mikos, A.G., and Patrick, C.W. Jr. Bioactive poly(L-lactic acid) conduits seeded with Schwann cells for peripheral nerve regeneration. Biomaterials 23, 841, 2002.
34. Rezwan, K., Chen, Q.Z., Blaker, J.J., and Boccaccini, A.R. Biodegradable and bioactive porous polymer/inorganic composite scaffolds for bone tissue engineering. Biomater-ials 27, 3413, 2006.
35. Paszek, M.J., Zahir, N., Johnson, K.R., Lakins, J.N., Rozen-berg, G.I., Gefen, A., Reinhart-King, C.A., Margulies, S.S., Dembo, M., Boettiger, D., Hammer, D.A., and Weaver, V.M. Tensional homeostasis and the malignant phenotype. Cancer Cell 8, 241, 2005.
36. Rosines, E., Schmidt, H.J., and Nigam, S.K. The effect of hyaluronic acid size and concentration on branching morphogenesis and tubule differentiation in developing kidney culture systems: potential applications to engineering of renal tissues. Biomaterials 28, 4806, 2007.
37. Egles, C., Shamis, Y., Mauney, J.R., Volloch, V., Kaplan, D.L., and Garlick, J.A. Denatured collagen modulates the pheno-type of normal and wounded human skin equivalents. J Invest Dermatol 128, 1830, 2008
38. Wang, Y., Rudym, D.D., Walsh, A., Abrahamsen, L., Kim, H.J., Kim, H.S., Kirker-Head, C., and Kaplan, D.L. In vivo degradation of three-dimensional silk fibroin scaffolds. Bio-materials 29, 3415, 2008.
39. Nickel, C., Benzing, T., Sellin, L., Gerke, P., Karihaloo, A., Liu, Z.X., Cantley, L.G., and Walz, G. The polycystin-1 C-terminal fragment triggers branching morphogenesis and migration of tubular kidney epithelial cells. J Clin Invest 9, 481, 2002.
40. Rhee, S., and Grinnell, F. Fibroblast mechanics in 3D collagen matrices. Adv Drug Deliv Rev 59, 1299, 2007.
41. Grinnell, F., Ho, C.H., Tamariz, E., Lee, D.J., and Skuta, G. Dendritic fibroblasts in three-dimensional collagen matrices. Mol Biol Cell 14, 384, 2003.
42. Tamariz, E., and Grinnell, F. Modulation of fibroblast morphology and adhesion during collagen matrix remodeling. Mol Biol Cell 13, 3915, 2002.
43. Xia, H., Nho, R., Kleidon, J., Kahm, J., and Henke, C.A. Polymerized collagen inhibits fibroblast proliferation via a mechanism involving the formation of a beta1 integrin-protein phosphatase 2A-tuberous sclerosis complex2 complex that suppresses S6K1 activity. J Biol Chem 283, 20350, 2008.
44. Montesano, R., Matsumoto, K., Nakamura, T., and Orci, L. Identification of a fibroblast-derived epithelial morphogen as hepatocyte growth factor. Cell 29, 901, 1991.
45. Rosines, E., Sampogna, R.V., Johkura, K., Vaughn, D.A., Choi, Y., Sakurai, H., Shah, M.M., and Nigam, S.K. Staged in vitro reconstitution and implantation of engineered rat kidney tissue. Proc Natl Acad Sci USA 104, 20938, 2007.
46. Okada, T.S. The expression of cell adhesion molecules, cadherins: markers of kidney morphogenesis. Pediatr Ne-phrol 2, 115, 1988.
47. Sweet, D.H., Eraly, S.A., Vaughn, D.A., Bush, K.T., and Nigam, S.K. Organic anion and cation transporter expression and function during embryonic kidney development and in organ culture models. Kidney Int 69, 837, 2006.
48. Saxén, L., and Lehtonen, E. Embryonic kidney in organ culture. Differentiation 36, 2, 1987.
49. Iwahori, T., Matsuno, N., Johjima, Y., Konno, O., Akashi, I., Nakamura, Y., Hama, K., Iwamoto, H., Uchiyama, M., Ashizawa, T., and Nagao, T. Radial flow bioreactor for the creation of bioartificial liver and kidney. Transplant Proc 37, 212, 2005.
50. Humes, H.D., MacKay, S.M., Funke, A.J., and Buffington, D.A. Tissue engineering of a bioartificial renal tubule assist device: in vitro transport and metabolic characteristics. Kidney Int 55, 2502, 1999.